Retour
Fourchette du Jour
10,92 €
11,44 €
Fourchette 52 Semaines
5,30 €
14,85 €
Volume
200 530
Moyenne 50J / 200J
12,40 €
/
9,41 €
Clôture Précédente
10,97 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -12,5 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | -12,0 | 3,7 |
| Net Margin % | -7,9 | 3,8 |
| Rev Growth 5Y % | -0,2 | 10,0 |
| D/E | 1,4 | 0,2 |
Points Clés
Revenue declined -0,17% annually over 5 years
Generating 2,00B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,90%
Capital efficient — spends only 5,46% of revenue on capex
Croissance
Revenue Growth (5Y)
-0,17%
Revenue (1Y)-6,07%
Earnings (1Y)N/A
FCF Growth (3Y)-8,02%
Qualité
Return on Equity
-12,02%
ROIC7,91%
Net Margin-7,94%
Op. Margin15,26%
Sécurité
Debt / Equity
1,44
Current Ratio1,00
Interest Coverage4,04
Valorisation
P/E Ratio
-12,49
P/B Ratio1,67
EV/EBITDA11,11
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,07% | Revenue Growth (3Y) | -4,14% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,17% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 43,78B | Net Income (TTM) | -3,48B |
| ROE | -12,02% | ROA | -3,15% |
| Gross Margin | 59,21% | Operating Margin | 15,26% |
| Net Margin | -7,94% | Free Cash Flow (TTM) | 2,00B |
| ROIC | 7,91% | FCF Growth (3Y) | -8,02% |
| Safety | |||
| Debt / Equity | 1,44 | Current Ratio | 1,00 |
| Interest Coverage | 4,04 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -12,49 | P/B Ratio | 1,67 |
| P/S Ratio | 0,99 | PEG Ratio | -0,29 |
| EV/EBITDA | 11,11 | Dividend Yield | 0,00% |
| Market Cap | 43,42B | Enterprise Value | 74,18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 43,78B | 46,61B | 47,64B | 50,74B | 44,08B |
| Net Income | -3,48B | -2,55B | -2,94B | 4,15B | 1,00B |
| EPS (Diluted) | -0,88 | -0,65 | -0,75 | 1,06 | 0,26 |
| Gross Profit | 25,92B | 25,34B | 27,89B | 30,87B | 27,27B |
| Operating Income | 6,68B | 3,33B | -150,00M | 6,26B | 6,98B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 110,56B | 110,85B | 116,26B | 124,88B | 120,24B |
| Total Liabilities | 84,51B | 78,81B | 83,18B | 85,95B | 87,07B |
| Shareholders' Equity | 25,94B | 31,91B | 32,93B | 38,77B | 33,02B |
| Total Debt | 37,43B | 40,70B | 44,79B | 41,65B | 39,53B |
| Cash & Equivalents | 6,67B | 6,19B | 5,91B | 5,17B | 4,56B |
| Current Assets | 32,43B | 34,44B | 37,56B | 37,76B | 32,58B |
| Current Liabilities | 32,57B | 28,95B | 29,46B | 35,08B | 29,40B |